Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of three bowel preparation medication regimens before colonoscopy
IRCT20240828062893N2Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Mar 2025
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of dimeticone, bisacodyl and macrogol (3 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Bowel evacuation rate. Started Mar 2025; status: completed.
02
Drugs
dimeticonebisacodylmacrogol
Beyond the preview
Go deeper on IRCT20240828062893N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240828062893N2.